Is acute lymphoblastic leukemia with mature B-cell phenotype and KMT2A rearrangements a new entity? A systematic review and meta-analysis

References

• Swerdlow S, Campo E, Harris N, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Vol. 2. Lyon (France): IARC; 2017.
   Google Scholar
• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2406.
   PubMed Web of Science ®Google Scholar
• Bain BJ. Leukaemia Diagnosis. 4th ed. John Wiley & Sons, Incorporated; 2010.
   Google Scholar
• Borkhardt A, Wuchter C, Viehmann S, et al. Infant acute lymphoblastic leukemia – combined cytogenetic, immunophenotypical and molecular analysis of 77 cases. Leukemia. 2002;16(9):1685–1690.
   PubMed Web of Science ®Google Scholar
• Tsao L, Draoua HY, Osunkwo I, et al. Mature B-cell acute lymphoblastic leukemia with t(9;11) translocation: a distinct subset of B-cell acute lymphoblastic leukemia. Mod Pathol. 2004;17(7):832–839.
   PubMed Web of Science ®Google Scholar
• Kim B, Lee ST, Kim HJ, et al. Acute lymphoblastic leukemia with mature B-cell phenotype and t(9;11;11)(p22;q23;p11.2): a case study and literature review. Ann Lab Med. 2014;34(2):166–169.
   PubMed Web of Science ®Google Scholar
• Bai L, Cheng Y. f, Lu A. d, et al. Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemia. Leuk Res. 2020:91:106333.
   Web of Science ®Google Scholar
• Pieters R, Lorenzo PD, Ancliffe P, et al. Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the interfant-06 protocol: results from an international phase III randomized study. J Clin Oncol. 2019;37(25):2246–2257.
   PubMed Web of Science ®Google Scholar
• Meyer C, Burmeister T, Gröger D, et al. The MLL recombinome of acute leukemias in 2017. Leukemia. 2018;32(2):273–284.
   PubMed Web of Science ®Google Scholar
• Ayton PM, Cleary ML. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 2001;20(40):5695–5707.
   PubMed Web of Science ®Google Scholar
• Lafage-Pochitaloff M, Baranger L, Hunault M, et al. Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia. Blood. 2017;130(16):1832–1844.
   PubMed Web of Science ®Google Scholar
• Sajaroff EO, Mansini A, Rubio P, et al. B-cell acute lymphoblastic leukemia with mature phenotype and MLL rearrangement: report of five new cases and review of the literature. Leuk Lymphoma. 2016;57(10):2289–2297.
   PubMed Web of Science ®Google Scholar
• Frater JL, Batanian JR, O'Connor DM, et al. Lymphoblastic leukemia with mature B-cell phenotype in infancy. J Pediatr Hematol Oncol. 2004;26(10):672–677.
   Web of Science ®Google Scholar
• Blin N, Méchinaud F, Talmant P, et al. Mature B-cell lymphoblastic leukemia with MLL rearrangement: an uncommon and distinct subset of childhood acute leukemia. Leukemia. 2008;22(5):1056–1059.
   PubMed Web of Science ®Google Scholar
• McGowan-Jordan J, Simons A, Schmid M. An international system for human cytogenomic nomenclature. Basel (Switzerland): Karger; 2016. p. 1–140.
   Google Scholar
• Van Dongen JJM, Macintyre EA, Gabert JA, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 concerted action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999;13(12):1901–1928.
   PubMed Web of Science ®Google Scholar
• van der Linden MH, Boer JM, Schneider P, et al. Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities Wild-type. Haematologica. 2016;101(3):e95–e98.
   PubMed Web of Science ®Google Scholar
• Li S, Lew G. Is B-lineage acute lymphoblastic leukemia with a mature phenotype and l1 morphology a precursor B-lymphoblastic leukemia/lymphoma or Burkitt leukemia/lymphoma? Arch Pathol Lab Med. 2003;127(10):1340–1344.
   PubMed Web of Science ®Google Scholar
• Petrovici K, Graf M, Hecht K, et al. Use of NG2 (7.1) in AML as a tumor marker and its association with a poor prognosis. Cancer Genomics Proteomics. 2010;7(4):173–180.
   PubMedGoogle Scholar
• Prieto C, López-Millán B, Roca-Ho H, et al. NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL. Leukemia. 2018;32(3):633–644.
   PubMed Web of Science ®Google Scholar
• Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–447.
   PubMed Web of Science ®Google Scholar
• Kotecha RS, Gottardo NG, Kees UR, et al. The evolution of clinical trials for infant acute lymphoblastic leukemia. Blood Cancer J. 2014;4:e200.
   PubMed Web of Science ®Google Scholar
• Bueno C, Montes R, Catalina P, et al. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement. Leukemia. 2011;25(3):400–410.
   PubMed Web of Science ®Google Scholar
• Hsi. Abstract. Society of Hematopathology/European Association of Hematopathology Workshop- Pediatric Hematopathology cases.
   Google Scholar
• Lorsbach. Abstract. Society of Hematopathology/ European Association of Hematopathology Workshop- Pediatric Hematopathology cases.
   Google Scholar
• Lorenzana AN, Rubin CM, Le Beau MM, et al. Immunoglobulin gene rearrangements in acute lymphoblastic leukemia with the 9;11 translocation. Genes Chromosomes Cancer. 1991;3(1):74–77.
   PubMed Web of Science ®Google Scholar
• Behm F, Head D, Pui C. B-precursor ALL with unexpected expression of surface immunoglobulin (slg) Mu and Lambda [abstract]. Lab Invest. 1995;72(1):106A.
   Google Scholar
• Talmant P, Berger R, Robillard N, et al. Childhood B-cell acute lymphoblastic leukemia with FAB-L1 morphology and a t(9;11) translocation involving the MLL gene. Hematol Cell Ther. 1996;38(3):265–268.
   PubMedGoogle Scholar
• Lim L, Chen KS, Krishnan S, et al. Mature B-cell acute lymphoblastic leukaemia associated with a rare MLL-FOXO4 fusion gene. Br J Haematol. 2012;157(6):651.
   PubMed Web of Science ®Google Scholar
• Sarashina T, Iwabuchi H, Miyagawa N, et al. Hematopoietic stem cell transplantation for pediatric mature B-cell acute lymphoblastic leukemia with non-L3 morphology and MLL-AF9 gene fusion: three case reports and review of the literature. Int J Hematol. 2016;104(1):139–143.
   PubMed Web of Science ®Google Scholar
• Yao Q, Liu Y, Fang Y, et al. Childhood B-cell acute lymphoblastic leukemia of nonL3 morphology with mature phenotype and MLL-AF9 gene fusion: a case report and literatures review. Chinese J Hematol. 2018;39:947–949. [Article in Chinese]
   Google Scholar
• Guo Y, Zhou M, Zou P, et al. Mature B cell acute lymphoblastic leukemia with MLL-AF9 transcripts: three case reports and literature reviews; 2020. doi:10.21203/rs.3.rs-33713/v1.
   Google Scholar